Zhejiang Shapuaisi Pharmaceutical Co Ltd Tangible Net Worth Ratio
Zhejiang Shapuaisi Pharmaceutical Co Ltd tangible net worth ratio. Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has a Tangible Net Worth Ratio of 85.8% as of September 2025. This metric is calculated by deducting intangible assets (CN¥229.38 Million) from net assets (CN¥1.62 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Zhejiang Shapuaisi Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
Tangible net worth ratio of Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024. This chart shows how Zhejiang Shapuaisi Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 17 annual periods from 2008 to 2024. As of September 2025, the ratio stands at 85.8%, reflecting net assets of CN¥1.62 Billion with intangible assets of CN¥229.38 Million CNY. See Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Zhejiang Shapuaisi Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (2008–2024)
Zhejiang Shapuaisi Pharmaceutical Co Ltd tangible net worth ratio by year from 2008 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 603168 company net worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 86.4% | CN¥1.59 Billion | CN¥215.83 Million | CN¥2.11 Billion | ▼ -3.1 pp |
| 2023 | 89.5% | CN¥1.73 Billion | CN¥181.42 Million | CN¥2.17 Billion | ▼ -1.2 pp |
| 2022 | 90.7% | CN¥1.72 Billion | CN¥160.14 Million | CN¥1.96 Billion | ▲ +2.9 pp |
| 2021 | 87.7% | CN¥1.35 Billion | CN¥165.72 Million | CN¥1.59 Billion | ▲ +1.3 pp |
| 2020 | 86.4% | CN¥1.31 Billion | CN¥177.29 Million | CN¥1.67 Billion | ▼ -10.1 pp |
| 2019 | 96.6% | CN¥1.49 Billion | CN¥51.15 Million | CN¥1.59 Billion | ▲ +1.1 pp |
| 2018 | 95.5% | CN¥1.48 Billion | CN¥66.62 Million | CN¥1.65 Billion | ▼ -1.0 pp |
| 2017 | 96.5% | CN¥1.66 Billion | CN¥57.45 Million | CN¥1.87 Billion | ▲ +0.2 pp |
| 2016 | 96.4% | CN¥1.59 Billion | CN¥57.95 Million | CN¥1.84 Billion | ▲ +3.2 pp |
| 2015 | 93.2% | CN¥891.62 Million | CN¥60.78 Million | CN¥1.27 Billion | ▼ -2.8 pp |
| 2014 | 96.0% | CN¥762.90 Million | CN¥30.52 Million | CN¥872.34 Million | ▲ +4.9 pp |
| 2013 | 91.1% | CN¥353.31 Million | CN¥31.33 Million | CN¥597.57 Million | ▲ +0.6 pp |
| 2012 | 90.6% | CN¥274.21 Million | CN¥25.83 Million | CN¥516.54 Million | ▲ +3.7 pp |
| 2011 | 86.9% | CN¥201.95 Million | CN¥26.54 Million | CN¥327.38 Million | ▼ -8.1 pp |
| 2010 | 95.0% | CN¥152.04 Million | CN¥7.65 Million | CN¥222.49 Million | ▲ +1.9 pp |
| 2009 | 93.0% | CN¥109.67 Million | CN¥7.64 Million | CN¥186.82 Million | ▲ +1.5 pp |
| 2008 | 91.6% | CN¥93.58 Million | CN¥7.90 Million | CN¥162.82 Million | — |